Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Hydrocortisone (modified release tablet)

EU orphan designation number: EU/3/07/441   
Active ingredient: Hydrocortisone (modified release tablet)
Indication: Treatment of adrenal insufficiency
Sponsor: Diurnal Limited
Cardiff Medicentre, Heath Park, Cardiff CF14 4UJ, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/03/2007 Centralised Orphan - Designation EMEA/OD/095/06 (2007)1325 of 20/03/2007
23/02/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/095/06/T/01 (2009)1184 of 17/02/2009
16/10/2009 Other procedure
08/07/2014 Centralised Orphan - Change of address